References
- WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Tech. Rep. Ser.894, 1–253 (2000).
- Nguyen DM, El-Serag HB. The big burden of obesity. Gastrointest. Endosc.70, 752–757 (2009).
- Mossberg HO. 40-year follow-up of overweight children. Lancet2, 491–493 (1989).
- Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA303, 242–249 (2010).
- Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003–2006. JAMA299, 2401–2405 (2008).
- Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med.355, 763–778 (2006).
- Whitlock G, Lewington S, Sherliker P et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet373, 1083–1096 (2009).
- Pischon T, Boeing H, Hoffmann K et al. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med.359, 2105–2120 (2008).
- Olshansky SJ, Passaro DJ, Hershow RC et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med.352, 1138–1145 (2005).
- Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology132, 2253–2271 (2007).
- Ward M, Prachand V. Surgical treatment of obesity. Gastrointest. Endosc.70, 985–990 (2009).
- Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA294, 1909–1917 (2005).
- Doherty C. Vertical banded gastroplasty. Surg. Clin. North Am.81, 1097–1112 (2001).
- Magnusson M, Freedman J, Jonas E, Stockeld D, Granstrom L, Naslund E. Five-year results of laparoscopic vertical banded gastroplasty in the treatment of massive obesity. Obes. Surg.12, 826–830 (2002).
- Aggarwal S, Kini SU, Herron DM. Laparoscopic sleeve gastrectomy for morbid obesity: a review. Surg. Obes. Relat. Dis.3, 189–194 (2007).
- Griffen WO Jr, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg. Gynecol. Obstet.157, 301–308 (1983).
- Marceau P, Hould FS, Lebel S, Marceau S, Biron S. Malabsorptive obesity surgery. Surg. Clin. North Am.81, 1113–1127 (2001).
- Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes. Surg.15, 408–416 (2005).
- Livingston EH. Complications of bariatric surgery. Surg. Clin. North Am.85, 853–868 (2005).
- Abell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am. J. Med. Sci.331, 214–218 (2006).
- Decker GA, Swain JM, Crowell MD, Scolapio JS. Gastrointestinal and nutritional complications after bariatric surgery. Am. J. Gastroenterol.102, 2571–2580 (2007).
- Lee CW, Kelly JJ, Wassef WY. Complications of bariatric surgery. Curr. Opin. Gastroenterol.23, 636–643 (2007).
- Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst. Rev.2, CD003641 (2009).
- Flum DR, Belle SH, King WC, Perioperative safety in the longitudinal assessment of bariatric surgery. N. Engl. J. Med.361, 445–454 (2009).
- Tsesmeli N, Coumaros D. Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses. Endoscopy41, 1082–1089 (2009).
- Mathus-Vliegen EM. Intragastric balloon treatment for obesity: what does it really offer? Dig. Dis.26, 40–44 (2008).
- Kotzampassi K, Shrewsbury AD. Intragastric balloon: ethics, medical need and cosmetics. Dig. Dis.26, 45–48 (2008).
- Schauer P, Chand B, Brethauer S. New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg. Endosc.21, 347–356 (2007).
- Anderson MA, Gan SI, Fanelli RD et al. Role of endoscopy in the bariatric surgery patient. Gastrointest. Endosc.68, 1–10 (2008).
- Cote GA, Edmundowicz SA. Emerging technology: endoluminal treatment of obesity. Gastrointest. Endosc.70, 991–999 (2009).
- Stylopoulos N, Aguirre V. Mechanisms of bariatric surgery and implications for the development of endoluminal therapies for obesity. Gastrointest. Endosc.70, 1167–1175 (2009).
- Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet1, 198–199 (1982).
- Oesch S, Ruegg C, Fischer B, Degen L, Beglinger C. Effect of gastric distension prior to eating on food intake and feelings of satiety in humans. Physiol. Behav.87, 903–910 (2006).
- Lal S, McLaughlin J, Barlow J et al. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am. J. Physiol. Gastrointest. Liver Physiol.287, G72–G79 (2004).
- McFarland RJ, Grundy A, Gazet JC, Pilkington TR. The intragastric balloon: a novel idea proved ineffective. Br. J. Surg.74, 137–139 (1987).
- Schapiro M, Benjamin S, Blackburn G et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19–21, 1987. Gastrointest. Endosc.33, 323–327 (1987).
- Allison C. Intragastric balloons: a temporary treatment for obesity. Issues Emerg. Health Technol.79, 1–4 (2006).
- Roman S, Napoleon B, Mion F et al. Intragastric balloon for ‘non-morbid’ obesity: a retrospective evaluation of tolerance and efficacy. Obes. Surg.14, 539–544 (2004).
- De Waele B, Reynaert H, Urbain D, Willems G. Intragastric balloons for preoperative weight reduction. Obes. Surg.10, 58–60 (2000).
- Dumonceau JM. Evidence-based review of the bioenterics intragastric balloon for weight loss. Obes. Surg.18, 1611–1617 (2008).
- Herve J, Wahlen CH, Schaeken A et al. What becomes of patients one year after the intragastric balloon has been removed? Obes. Surg.15, 864–870 (2005).
- Martinez-Brocca MA, Belda O, Parejo J et al. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes. Surg.17, 649–657 (2007).
- Fernandes M, Atallah AN, Soares BG et al. Intragastric balloon for obesity. Cochrane Database Syst. Rev.1, CD004931 (2007).
- Angrisani L, Lorenzo M, Borrelli V, Giuffre M, Fonderico C, Capece G. Is bariatric surgery necessary after intragastric balloon treatment? Obes. Surg.16, 1135–1137 (2006).
- Melissas J, Mouzas J, Filis D et al. The intragastric balloon – smoothing the path to bariatric surgery. Obes. Surg.16, 897–902 (2006).
- Wahlen CH, Bastens B, Herve J et al. The bioenterics intragastric balloon (BIB): how to use it. Obes. Surg.11, 524–527 (2001).
- Galloro G, Sivero L, Magno L et al. New technique for endoscopic removal of intragastric balloon placed for treatment of morbid obesity. Obes. Surg.17, 658–662 (2007).
- Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, Sendra-Gutierrez JM, Gonzalez-Enriquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes. Surg.18, 841–846 (2008).
- Goldstein DJ. Beneficial health effects of modest weight loss. Int. J. Obes. Relat. Metab. Disord.16, 397–415 (1992).
- Genco A, Cipriano M, Bacci V et al. Bioenterics intragastric balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int. J. Obes. (Lond.)30, 129–133 (2006).
- Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest. Endosc.61, 19–27 (2005).
- Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50). Obes. Surg.15, 612–617 (2005).
- Genco A, Cipriano M, Materia A et al. Laparoscopic sleeve gastrectomy versus intragastric balloon: a case–control study. Surg. Endosc.23, 1849–1853 (2009).
- Forestieri P, De Palma GD, Formato A et al. Heliosphere bag in the treatment of severe obesity: preliminary experience. Obes. Surg.16, 635–637 (2006).
- Mion F, Gincul R, Roman S et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes. Surg.17, 764–769 (2007).
- Trande P, Mussetto A, Mirante VG et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere bag) for obesity: the experience of 17 cases. Obes. Surg.20, 1227–1230 (2008).
- Matar ZS, Mohamed AA, Abukhater M, Hussien M, Emran F, Bhat NA. Small bowel obstruction due to air-filled intragastric balloon. Obes. Surg.19, 1727–1730 (2009).
- Naslund E, Freedman J, Lagergren J, Stockeld D, Granstrom L. Three-year results of laparoscopic vertical banded gastroplasty. Obes. Surg.9, 369–373 (1999).
- Sjostrom L, Narbro K, Sjostrom CD et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med.357, 741–752 (2007).
- Morino M, Toppino M, Bonnet G, Rosa R, Garrone C. Laparoscopic vertical banded gastroplasty for morbid obesity. Assessment of efficacy. Surg. Endosc.16, 1566–1572 (2002).
- Nocca D, Aggarwal R, Blanc P et al. Laparoscopic vertical banded gastroplasty. A multicenter prospective study of 200 procedures. Surg. Endosc.21, 870–874 (2007).
- Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long-term results comparing three different techniques. Obes. Surg.10, 41–46 (2000).
- Jafri SM, Arora G, Triadafilopoulos G. What is left of the endoscopic antireflux devices? Curr. Opin. Gastroenterol.25, 352–357 (2009).
- Fogel R, De FJ, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest. Endosc.68, 51–58 (2008).
- Fogel R, Rams H, Greer P et al. Endoluminal vertical gastroplasty for weight reduction – a U.S. study of 30 patients with up to 18 months follow-up. Gastroenterology136, A384 (2009).
- Fogel R, De Fogel J. Trans-oral vertical gastroplasty as a viable treatment for childhood obesity – a study of 21 adolescents with up to 18 months of follow-up. Gastrointest. Endosc.69, AB169–AB170 (2009).
- Bessler M. Endoluminal treatment of obesity: the dawn of a new era? Gastrointest. Endosc.68, 59–60 (2008).
- Deviere J, Ojeda Valdes G, Cuevas Herrera L et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg. Endosc.22, 589–598 (2008).
- Moreno C, Closset J, Dugardeyn S et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy40, 406–413 (2008).
- Familiari P, Perri V, Boskoski I et al. Transoral gastroplasty (TOGA): interim results of a pilot study at 1-year follow-up. Dig. Liver Dis.42, S176 (2010).
- de Jong K, Mathus-Vliegen EM, Veldhuyzen EA, Eshuis JH, Fockens P. Short-term safety and efficacy of the trans-oral endoscopic restrictive implant system for the treatment of obesity. Gastrointest. Endosc.72, 497–504 (2010).
- Thompson CC, Brethauer SA, Chand B, Lautz DB, Kaplan LM, Schauer PR. Transoral gastric volume reduction as an intervention for weight management (TRIM) multicenter feasibility study: a report of early outcomes. Gastroenterology136, A384 (2009).
- Brethauer S, Thompson CC, Chand B, Schauer P. ET-101 transoral gastric volume reduction as an intervention for weight management: 12 month follow-up of the trim trial. Surgery for Obesity and Related Diseases7(3), 363 (2011).
- Hu B, Chung SC, Sun LC et al. Transoral obesity surgery: endoluminal gastroplasty with an endoscopic suture device. Endoscopy37, 411–414 (2005).
- Kantsevoy SV, Hu B, Jagannath SB et al. Technical feasibility of endoscopic gastric reduction: a pilot study in a porcine model. Gastrointest. Endosc.65, 510–513 (2007).
- Vegesna AK, Besetty R, Tiwana MI et al. Pyloric suture narrowing trial to treat obesity (a canine model). Gastrointest. Endosc.69, AB259 (2009).
- Oelschlager BK, Soares RV, Montenovo MI, Wright AS, Hwang JHA. Endoluminal gastroplasty: a novel suturing device making endolumenal bariatric surgery a reality. Gastrointest. Endosc.69, AB166–AB167 (2009).
- Stadlhuber RJ, Yano F, Mittal SK, Rosenthal RJ, Rothstein RI, Filipi CJ. A new transoral gastroplasty device for GERD and obesity. Gastrointest. Endosc.67, AB90–AB91 (2008).
- Chuttani R, Pleskow D, Ornellas L. endoscopic restrictive gastroplasty using full-thickness plication. Gastrointest. Endosc.63, AB224 (2006).
- Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg. Obes. Relat. Dis.4, 55–59 (2008).
- Tarnoff M, Rodriguez L, Escalona A et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg. Endosc.23, 650–656 (2009).
- Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM. An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity16, 2585–2592 (2008).
- Tarnoff M, Shikora S, Lembo A. Acute technical feasibility of an endoscopic duodenal-jejunal bypass sleeve in a porcine model: a potentially novel treatment for obesity and Type 2 diabetes. Surg. Endosc.22, 772–776 (2008).
- Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of Type 2 diabetes: a new perspective for an old disease. Ann. Surg.239, 1–11 (2004).
- Zheng J, DiLorenzo DJ, McLaughlin L, Roberts AT, Greenway FL. Stimulation of sympathetic innervation in the upper gastrointestinal tract as a treatment for obesity. Med. Hypotheses72, 706–710 (2009).
- Cigaina V, Hirschberg AL. Plasma ghrelin and gastric pacing in morbidly obese patients. Metabolism56, 1017–1021 (2007).
- Favretti F, De LM, Segato G et al. Treatment of morbid obesity with the transcend implantable gastric stimulator (IGS): a prospective survey. Obes. Surg.14, 666–670 (2004).
- Bohdjalian A, Ludvik B, Guerci B et al. Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with Type 2 diabetes. Surg. Endosc.23, 1955–1960 (2009).
- Sallam HS, Chen JD, Pasricha PJ. Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. Gastrointest. Endosc.68, 754–759 (2008).
- Abell TL, Minocha A, Garretson R, Abidi N. Endoscopic temporary gastric electrical stimulation: results of 140 consecutive patients. Gastrointest. Endosc.63, AB103 (2006).
- Garcia-Compean D, Maldonado GH. Intragastric injection of botulinum toxin for the treatment of obesity. Where are we? World J. Gastroenterol.14, 1805–1809 (2008).
- Scozzari G, Farinella E, Bonnet G, Toppino M, Morino M. Laparoscopic adjustable silicone gastric banding vs laparoscopic vertical banded gastroplasty in morbidly obese patients: long-term results of a prospective randomized controlled clinical trial. Obes. Surg.19, 1108–1115 (2009).
- Ojo P, Valin E. Cost-effective restrictive bariatric surgery: laparoscopic vertical banded gastroplasty versus laparoscopic adjustable gastric band. Obes. Surg.19, 1536–1541 (2009).
- Miller K, Pump A, Hell E. Vertical banded gastroplasty versus adjustable gastric banding: prospective long-term follow-up study. Surg. Obes. Relat. Dis.3, 84–90 (2007).
- Morino M, Toppino M, Bonnet G, del Genio G. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann. Surg.238, 835–841 (2003).
- O’Brien PE, Dixon JB, Laurie C et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann. Intern. Med.144, 625–633 (2006).
- Angrisani L, Favretti F, Furbetta F et al. Italian group for lap-band system: results of multicenter study on patients with BMI < or =35 kg/m2. Obes. Surg.14, 415–418 (2004).
Websites
- Medical device alert: Heliosphere bag intragastric balloon (MDA/2009/040) www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON049233
- Transoral Gastric Volume Reduction as an Intervention for Weight Management (TRIM) http://clinicaltrials.gov/ct2/show/NCT00679848?term=TGVR&rank=1
- Clinical trials – EndoBarrier http://clinicaltrials.gov/ct2/results?term=ENDOBARRIER
- Position Statement – Chirurgia Bariatrica BMI 30–35 e Comorbidità www.sicob.org/00_materiali/attivita/statement_BMI_30_35.pdf